Literature DB >> 11259994

Prescribers prefer people: The sources of information used by doctors for prescribing suggest that the medium is more important than the message.

P McGettigan1, J Golden, J Fryer, R Chan, J Feely.   

Abstract

AIMS: The sources of prescribing information are legion but there is little knowledge about which are actually used in practice by doctors when prescribing. The aims of this study were to determine the sources of prescribing information considered important by doctors, establish which were used in practice, and investigate if hospital and primary care physicians differed in their use of the sources.
METHODS: Two hundred general practitioners (GPs) and 230 hospital doctors were asked to rate information sources in terms of their importance for prescribing 'old' and 'new' drugs, and then to name the source from which information about the last new drug prescribed was actually derived.
RESULTS: Among 108 GPs, the Drugs and Therapeutics Bulletin and medical journal articles were most frequently rated as important for information on both old and new drugs while pharmaceutical representatives and hospital/consultant recommendations were more important for information on new drugs, as opposed to old. In practice, information on the last new drug prescribed was derived from pharmaceutical representatives in 42% of cases and hospital/consultant recommendations in 36%, with other sources used infrequently. Among 118 hospital doctors, the British National Formulary (BNF) and senior colleagues were of greatest theoretical importance. In practice, information on the last new drug prescribed was derived from a broad range of sources: colleagues, 29%; pharmaceutical representatives, 18%; hospital clinical meetings, 15%; journal articles, 13%; lectures, 10%. GPs and hospital doctors differed significantly in their use of pharmaceutical representatives (42% vs 18%) and colleagues (7% vs 29%) as sources of prescribing information (P < 0.0001 for both).
CONCLUSIONS: The sources most frequently rated important in theory were not those most used in practice, especially among GPs. Both groups under-estimated the importance of pharmaceutical representatives. Most importantly, the sources of greatest practical importance were those involving the transfer of information through the medium of personal contact.

Entities:  

Mesh:

Year:  2001        PMID: 11259994      PMCID: PMC2014444          DOI: 10.1111/j.1365-2125.2001.01332.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  16 in total

1.  The pharmaceutical industry--to whom is it accountable?

Authors:  M Angell
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

2.  Principles of educational outreach ('academic detailing') to improve clinical decision making.

Authors:  S B Soumerai; J Avorn
Journal:  JAMA       Date:  1990-01-26       Impact factor: 56.272

3.  General practice postal surveys: a questionnaire too far?

Authors:  B R McAvoy; E F Kaner
Journal:  BMJ       Date:  1996-09-21

4.  Use of a tiered review for evaluation of appropriate use of hydroxymethylglutaryl coenzyme A reductase-inhibitor therapy.

Authors:  W E Strauss; G Alexis; R D Tapley
Journal:  Clin Ther       Date:  1999-02       Impact factor: 3.393

5.  A study of general practitioners' reasons for changing their prescribing behaviour.

Authors:  D Armstrong; H Reyburn; R Jones
Journal:  BMJ       Date:  1996-04-13

6.  Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing".

Authors:  J Avorn; S B Soumerai
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

7.  Scientific versus commercial sources of influence on the prescribing behavior of physicians.

Authors:  J Avorn; M Chen; R Hartley
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

8.  Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis.

Authors:  A C Nyquist; R Gonzales; J F Steiner; M A Sande
Journal:  JAMA       Date:  1998-03-18       Impact factor: 56.272

9.  The treatment of depression: prescribing patterns of antidepressants in primary care in the UK.

Authors:  J M Donoghue; A Tylee
Journal:  Br J Psychiatry       Date:  1996-02       Impact factor: 9.319

10.  Initial drug regimens for the treatment of tuberculosis: evaluation of physician prescribing practices in New Jersey, 1994 to 1995.

Authors:  Z Liu; K L Shilkret; L Finelli
Journal:  Chest       Date:  1998-06       Impact factor: 9.410

View more
  45 in total

1.  Dramaturgical study of meetings between general practitioners and representatives of pharmaceutical companies; Commentary: dramaturgical model gives valuable insight.

Authors:  M Somerset; M Weiss; T Fahey
Journal:  BMJ       Date:  2001 Dec 22-29

2.  Assessing the effects of an intervention by a pharmacist on prescribing and administration of hypnotics in nursing homes.

Authors:  E Eide; J Schjøtt; J Schjøt
Journal:  Pharm World Sci       Date:  2001-12

3.  Does participation in clinical trials influence the costs of future management of patients?

Authors:  Anne Hvenegaard; Henrik Hauschildt Juhl; Andreas Habicht
Journal:  Eur J Health Econ       Date:  2011-11-10

4.  Design and implementation of a common drug information database for a university hospital.

Authors:  Martin Dugas; Sonja Weinzierl; Alenka Pecar; Stefan Endres; Jörg Hasford
Journal:  Pharm World Sci       Date:  2003-08

5.  A systematic review of the clinical and economic impact of drug information services on patient outcome.

Authors:  David Hands; Martin Stephens; David Brown
Journal:  Pharm World Sci       Date:  2002-08

6.  Norwegian medical students' attitudes towards the pharmaceutical industry.

Authors:  Dordi Lea; Olav Spigset; Lars Slørdal
Journal:  Eur J Clin Pharmacol       Date:  2010-03-19       Impact factor: 2.953

7.  Access and use of medicines information sources by physicians in public hospitals in Uganda: a cross-sectional survey.

Authors:  Winifred A Tumwikirize; Jasper W Ogwal-Okeng; Osa Vernby; Willy W Anokbonggo; Lars L Gustafsson; Cecilia S Lundborg
Journal:  Afr Health Sci       Date:  2008-12       Impact factor: 0.927

8.  Health professionals: how do they assess new medicines?

Authors:  Rebecca Cheng; Kirsty Cook; Sarah Dowman; Rebecca Lawn; Jemma Leary; Taryn Quinn; Kim Schroder; Nicola Smith; June Tordoff
Journal:  Pharm World Sci       Date:  2005-06

9.  Impact of an evidence-based computerized decision support system on primary care prescription costs.

Authors:  S Troy McMullin; Thomas P Lonergan; Charles S Rynearson; Thomas D Doerr; Paul A Veregge; Edward S Scanlan
Journal:  Ann Fam Med       Date:  2004 Sep-Oct       Impact factor: 5.166

10.  Sources of information for new drugs among physicians in Thailand.

Authors:  Maneerat R Layton; Wanapa Sritanyarat; Supatra Chadbunchachai; Albert I Wertheimer
Journal:  Pharm World Sci       Date:  2007-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.